Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Galderma R&D
Further to this study, eligible Subjects with at least good Global Assessment of Improvement at Week 12 will be randomized in a maintenance study (SPR.29075)
Age
12–35
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female Subjects of any race, aged 12 to 35 years inclusive
Subjects with severe facial acne (global severity score of 4)
Subjects with a minimum of 20 inflammatory lesions (papules and pustules) on the face, excluding the nose
Subjects with a minimum of 30 and a maximum of 120 non-inflammatory lesions (open comedones and closed comedones) on the face, excluding the nose
You may not be if
Subjects with more than 3 nodules or cysts on the face,
